Rajesh Tammana

Chemveda Life Sciences is a mid-sized, fast-growing solution provider to the pharmaceutical, biotechnology, academia, and agrochemical industries. As a contract research partner Chemveda, is boosting its value creation along and beyond the drug discovery & development continuum, with an emphasis on churning out cost and timeline efficiencies for its global clientele. Chemveda harnesses its scientific and technological expertise to deliver full-suite Chemistry support from lab scale synthesis, to Process R&D, and large-scale custom development of drug substances, key intermediates, and starting materials across multiple chemistry classes. Lately, we have been investing in developing expertise in the most sought-after scientific platforms in order to answer the existing and evolving challenges in basic and applied research. Founded in 2008 and headquartered in Hyderabad, Chemveda is over 600 employees strong with a technology-based division of teams. We have our US presence in San Diego and also a team of same-time zone project managers & consultants deployed across all the major biotech hubs of US, Europe, and Asia. People have always been at the forefront of our growth, we have empowered them with the latest infrastructure, systems & processes, as well as a desired equipment ratio that is on par with or better than the industry standard. To take it up a notch, our able in-house scientific team draws its strengths and gets mentored by one of the most coveted and actively involved advisory boards with names like Prof. K.C. Nicolaou Prof. Phil S Baran, and Prof. Jin Quan Yu on board. As a collaborator, our offerings are built on a foundation of safeguarding the client's IP and a zero-conflict blend of investors. As we achieve the milestones of growth we wish to grow not only in terms of our scientific capabilities and human talent, but also by generating direct and indirect & qualitative as well as quantitative value for our clients, shareholders, and society.